Longitudinal Weight Outcomes From a Behavioral Lifestyle Intervention in Clinical Practice. Issue 5 (October 2019)

• Record Type: Journal Article
• Authors: Romanelli, Robert J.; Huang, Hsiao-Ching; Chopra, Vidita; Ma, Jun; Venditti, Elizabeth M.; Sudat, Sylvia; Greenwood, Deborah A.; Pressman, Alice R.; Azar, Kristen M. J.
• Is Part Of: Diabetes educator. Volume 45:Issue 5(2019)
• Page Start: 529
• Page End: 543
• Publication Date: 2019-10
• Subjects: Diabetes -- Study and teaching -- Periodicals; 616.462005
• DOI: 10.1177/0145721719872553
• Languages: English
• ISSNs: 0145-7217

Abstract

Purpose: The purpose of this electronic health record (EHR)–based retrospective cohort study was to characterize a population of patients participating in a 12-month, lifestyle change program in a community-based health system and to examine longitudinal weight outcomes. Methods: Program participants were identified in the EHRs of a health care delivery system across 18 sites between 2010 and 2017. Outcomes were mean weight change and proportion of patients with ≥5% weight loss through 24 months from program initiation. Results: Among 4463 program participants, 3156 met study eligibility criteria, with a mean ± SD age of 53.5 ± 13.1 years; 77.7% were women. Mean baseline weight ± SD was 101.3 ± 23.8 kg. Three main cardiometabolic risk groups were identified: prediabetes/high risk for diabetes (47.3%), overweight/obese in the absence of elevated diabetes risk (27.2%), and existing diabetes (23.9%). Maximal mean weight loss was 3.9% at 6 months from baseline. At 12 and 24 months from baseline, mean weight loss was 3.2% and 2.3%, respectively, with 31% and 29% of participants attaining ≥5% weight loss. Long-term weight outcomes were similar across risk groups. Conclusions: A lifestyle change program in a clinical practice setting is associated with modest weight loss, sustained through 24 months, among participants with a range of cardiometabolic risk factors. More than one-quarter of participants achieve ≥5% weight loss, regardless of cardiometabolic risk.